Biophorum, a leading consultancy in the biopharmaceutical industry, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 2015, the company has quickly established itself as a pivotal player in advancing biopharmaceutical manufacturing and innovation. Specialising in collaborative projects, Biophorum focuses on enhancing operational efficiency and driving technological advancements within the sector. Their unique approach fosters partnerships among industry stakeholders, enabling the development of best practices and innovative solutions tailored to the evolving needs of the market. With a commitment to quality and sustainability, Biophorum has achieved notable recognition for its contributions to the biopharmaceutical landscape, positioning itself as a trusted advisor and thought leader in the industry.
How does Biophorum's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biophorum's score of 25 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biophorum, headquartered in Great Britain, has set ambitious climate commitments aimed at achieving net zero emissions. While specific emissions data for the most recent year is not available, the company has outlined a significant target to reach net zero for Scope 3 emissions by 2050 at the latest. This commitment reflects a long-term strategy to address the broader impact of their operations, particularly in the supply chain and product lifecycle. In addition to their Scope 3 goals, Biophorum is also focused on reducing Scope 1 and 2 emissions, although specific reduction percentages have not been disclosed. These initiatives demonstrate Biophorum's dedication to sustainability and its proactive approach to mitigating climate change impacts within the biopharmaceutical industry.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biophorum is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.